Marcos Restrepo, MD, MSc
Basic profileThe University of Texas at San Antonio Health Science Center
Marcos Restrepo is a Respiratory physician affiliated with The University of Texas at San Antonio Health Science Center. OpenAlex indexes 520 publications with 25,030 citations (h-index 73); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7400 Merton Minter Blvd
San Antionio, TX 782294404
Telephone
210-617-5300Registry record last updated 8 Jul 2007.
Clinical trials
- Efficacy of Macrolide Immunomodulation in Severe Sepsis.
Sponsor: VA Office of Research and Development
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2010–2014 per NIH RePORTER. The latest:
- Effect of macrolides as immunomodulators in patients with sepsis and pneumonia
University of Texas Hlth Science Center
FY2014$137,700K23HL096054 - Effect of macrolides as immunomodulators in patients with sepsis and pneumonia
University of Texas Hlth Science Center
FY2013$137,700K23HL096054 - Effect of macrolides as immunomodulators in patients with sepsis and pneumonia
University of Texas Hlth Science Center
FY2012$137,700K23HL096054
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Intensive Care Medicine
2023 - ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
European Respiratory Journal
2023 - Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia
Intensive Care Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Dean Kellogg, MD
The University of Texas at San Antonio Health Science Center
Robert Brzyski, MD
The University of Texas at San Antonio Health Science Center
Devjit Tripathy, MD
The University of Texas at San Antonio Health Science Center
Robert Svatek, MD
The University of Texas at San Antonio Health Science Center
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”